Business Context and Reporting Period
This Form 8-K filing by SANUWAVE Health, Inc. reports corporate governance changes effective August 16, 2022. The company is incorporated in Nevada and maintains its principal executive offices in Suwanee, Georgia.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive appointments and compensation arrangements.
Material Changes
- Appointment of CFO: Dr. Toni Rinow was appointed Chief Financial Officer and designated as the principal financial officer.
- Role Transition: Lisa E. Sundstrom transitioned from the CFO role to Chief Talent Officer.
- Compensation Structure: Dr. Rinow's agreement includes an annual base salary of $335,000 and a potential annual cash bonus of up to 50% of her salary, split between company and personal performance goals.
- Equity Grant: Dr. Rinow is eligible for an option grant to purchase up to 6,000,000 shares of common stock, subject to board approval. Vesting is scheduled in three equal tranches: one-third upon signing, one-third on December 31, 2022, and one-third on December 31, 2023. As of the filing date, the grant had not occurred.
- Severance: In the event of involuntary separation, Dr. Rinow is entitled to a severance payment equivalent to one year's base salary.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary contingency noted is that the stock option grant is subject to approval by the Company's board of directors. Dr. Rinow is required to execute a separate non-competition and confidentiality agreement.
Investor Verification Checklist
- Verify the final approval status of the 6,000,000 share option grant for Dr. Rinow.
- Review the full text of the Offer Letter (Exhibit 10.1) for complete compensation terms.
- Confirm the effective date of Lisa E. Sundstrom's transition to Chief Talent Officer.
- Monitor future filings for the vesting schedule execution of the proposed equity award.